UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031551
Receipt number R000036021
Scientific Title A Study on Training Effect by Robot Suit HAL for Medical Use (Lower Limb Type) - Verification in patients with Parkinson's disease -
Date of disclosure of the study information 2018/03/27
Last modified on 2023/04/25 08:40:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on Training Effect by Robot Suit HAL for Medical Use (Lower Limb Type)
- Verification in patients with Parkinson's disease -

Acronym

A Study on Training Effect by Robot Suit HAL for Medical Use (Lower Limb Type)
- Verification in patients with Parkinson's disease -

Scientific Title

A Study on Training Effect by Robot Suit HAL for Medical Use (Lower Limb Type)
- Verification in patients with Parkinson's disease -

Scientific Title:Acronym

A Study on Training Effect by Robot Suit HAL for Medical Use (Lower Limb Type)
- Verification in patients with Parkinson's disease -

Region

Japan


Condition

Condition

Parkinson's disease

Classification by specialty

Neurology Neurosurgery Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to investigate the effect of rehabilitation with HAL for Medical Use (Lower Limb Type) in patients with Parkinson's disease.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II,III


Assessment

Primary outcomes

Timed up and Go test

Key secondary outcomes

age, gender, height, weight, disease duration, HDS-R, Hoehn & Yahr staging scale, Classification according to clinical diagnostic criteria of Parkinson's disease by MDS, MDSUPDRS part III, freezingof gait questionnaire(FOG-Q), 10m gait speed, step length, Berg Balance Scale(BBS), Video


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

The HAL group takes at first the HAL period followed by the conventional period.
In the HAL period, the patient performs 2 sets of rehabilitation of 5 days training with HAL for 60 minutes followed by 2 days conventional training for 40 minutes. In the conventional period, the patient performs 2 sets of conventional rehabilitation sessions of 5 days training for 60 minutes followed by 2 days training for 40 minutes.

Interventions/Control_2

The conventional group takes at first the conventional period followed by the HAL period.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

-Patients diagnosed as clinically established or clinically probable Parkinson's disease with Movement Disorder Society (MDS) clinical diagnostic criteria
-Patients who meet the stage 2-4 for Hoehn & Yahr staging scale
-Patients who consent with full understanding
-Patients judged that who are stable, and able to stand and walk
-Patients with the ability to stand and walk more than 10 m without assistance
-Patients' weight: 40 to 100 kg
-Patients' heights: 150 to 190 cm

Key exclusion criteria

-Patients planned to change the dose of anti-Parkinson's disease drug
-Patients judged as inappropriate for the walking training
-Patients have difficulties with wearing HAL
-Patients have difficulties with putting the electrodes on the skin
-Patients during pregnancy
-Patients have difficulties with understanding instructions

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Tetsuo
Middle name
Last name Ogawa

Organization

Nagoya City Rehabilitation Center

Division name

Department of Rehabilitation

Zip code

467-8622

Address

1-2 Mikanyama, Yatomi-cho, Mizuho-ku, Nagoya, Aichi, Japan

TEL

052-835-3811

Email

tets@tcp-ip.or.jp


Public contact

Name of contact person

1st name Yutaka
Middle name
Last name Kondou

Organization

Nagoya City Rehabilitation Center

Division name

Division of Physical Therapy

Zip code

467-8622

Address

1-2 Mikanyama, Yatomi-cho, Mizuho-ku, Nagoya, Aichi, Japan

TEL

052-835-3811

Homepage URL


Email

physical@nagoya-rehab.or.jp


Sponsor or person

Institute

Nagoya City Rehabilitation Agency

Institute

Department

Personal name



Funding Source

Organization

Nagoya City Rehabilitation Agency

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya City Rehabilitation Agency

Address

1-2 Mikanyama, Yatomi-cho, Mizuho-ku, Nagoya, Aichi, Japan

Tel

052-835-3811

Email

soumubu@nagoya-rehab.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名古屋市総合リハビリテーション事業団(愛知県)


Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

6

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2018 Year 03 Month 22 Day

Date of IRB

2018 Year 03 Month 27 Day

Anticipated trial start date

2018 Year 03 Month 27 Day

Last follow-up date

2020 Year 07 Month 25 Day

Date of closure to data entry


Date trial data considered complete

2020 Year 02 Month 01 Day

Date analysis concluded

2021 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2018 Year 03 Month 02 Day

Last modified on

2023 Year 04 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036021


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name